In terms of geographical distribution of capital investment in the field of early cancer detection, the USA leads with respect to the amount of capital invested from 2000-2023, followed by China and South Korea (Figure ). The amount of investment in the USA is ~5X more than that of China and ~7X more than South Korea. Growth in the number of deals made over the last two decades for the few leading countries/regions or regions shows a steady increase, excluding a minor dip seen in the number of deals in 2022 (Figure ). This trend indicates a continued interest of companies in the field of early cancer detection. Unsurprisingly, the USA has the highest number of deals followed by Europe and Asia. (Figure ). Regions / countries/regions from the Middle East and Africa also show a presence in the last 5 years (2018 onwards).